By Emeritus Professor Allan David Spigelman

Conference Papers

Talseth-Palmer BA; Brenne IS; Ashton K; Evans TJ; McPhillips M; Groombridge C; Kurzawski G; Spigelman A; Lubinski J; Scott RJ, 2010, 'Colorectal cancer susceptibility loci on chr 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 22 - 22, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70892-2

McGrath D; Frydoonfar H; Spigelman AD, 2007, 'Potential mechanisms for the chemoprotective effect of cruciferous vegetables in colorectal cancer: A clinical trial of indole-3-carbinol', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 41 - 41, presented at 5th International Symposium onTargeted Anticancer Therapies, NETHERLANDS, Amsterdam, 08 March 2007 - 10 March 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249280500076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Notarianni LJ; Oliver S; Bennett PN; Farmer KC; Spigelman A; Phillips RK, 1992, 'P4501A2 activity in patients with colorectal carcinoma and familial adenomatous polyposis (FAP) and their at risk relatives', in British Journal of Clinical Pharmacology, pp. 153

Back to profile page